{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T11:22:59Z","timestamp":1758280979546,"version":"3.41.0"},"reference-count":54,"publisher":"Radcliffe Medical Media Ltd","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"abstract":"<jats:p>In multivessel coronary artery disease (MVCAD), myocardial revascularisation can be achieved by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), with complete revascularisation on all diseased coronary segments or with incomplete revascularisation on selectively targeted lesions. Complete revascularisation confers a long-term prognostic benefit, but is associated with a higher rate of periprocedural events compared with incomplete revascularisation. In most patients with MVCAD, the main advantage of CABG over PCI is conferred by the achievement of more extensive revascularisation. According to current international guidelines, PCI is generally preferred in single-vessel disease, low-risk MVCAD or isolated left main disease; whereas CABG is usually recommended in patients with complex two-vessel disease, most patients with three-vessel disease and\/or non-isolated left main disease. In patients with MVCAD, the choice on revascularisation modality should depend on a multifactorial evaluation, taking into account not only coronary anatomy, the ischaemic burden, myocardial function, age and the presence of comorbidities, but also the adequacy of myocardial revascularisation.<\/jats:p>","DOI":"10.15420\/icr.2017:23:1","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T09:57:56Z","timestamp":1516096676000},"page":"45","source":"Crossref","is-referenced-by-count":11,"title":["Is Complete Revascularisation Mandated for all Patients with Multivessel Coronary Artery Disease?"],"prefix":"10.15420","volume":"13","author":[{"given":"Carlo De","family":"Innocentiis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Institute of Cardiology and Centre of Excellence on Ageing, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, Chieti, Italy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Zimarino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Institute of Cardiology and Centre of Excellence on Ageing, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, Chieti, Italy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele De","family":"Caterina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Institute of Cardiology and Centre of Excellence on Ageing, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, Chieti, Italy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6096","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Authors\/Task Force Members, Windecker S, Kolh P, Alfonso F, et al. 2014 ESC\/EACTS guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-619.","DOI":"10.1093\/eurheartj\/ehu278"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/CIR.0000000000000336","article-title":"2015 ACC\/AHA\/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: an update of the 2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF\/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"133","author":"Levine","year":"2016","unstructured":"2. Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC\/AHA\/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: an update of the 2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF\/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2016;133:1135-47.","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.ijcard.2013.05.004","article-title":"The adequacy of myocardial revascularization in patients with multivessel coronary artery disease","volume":"168","author":"Zimarino","year":"2013","unstructured":"3. Zimarino M, Curzen N, Cicchitti V, De Caterina R. The adequacy of myocardial revascularization in patients with multivessel coronary artery disease. Int J Cardiol 2013;168:1748-57.","journal-title":"Int J Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jacc.2013.05.033","article-title":"Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies","volume":"62","author":"Garcia","year":"2013","unstructured":"4. Garcia S, Sandoval Y, Roukoz H, et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol 2013;62:1421-31.","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ccd.25923","article-title":"Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: a meta-analysis of randomized and observational studies","volume":"8","author":"Zimarino","year":"2016","unstructured":"5. Zimarino M, Ricci F, Romanello M, et al. Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: a meta-analysis of randomized and observational studies. Catheter Cardivasc Interv 2016;8:3-12.","journal-title":"Catheter Cardivasc Interv"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.jcin.2017.04.037","article-title":"Comparison of stenting versus bypass surgery according to the completeness of revascularization in severe coronary artery disease: patient-level pooled analysis of the SYNTAX, PRECOMBAT, and BEST Trials","volume":"10","author":"Ahn","year":"2017","unstructured":"6. Ahn JM, Park DW, Lee CW, et al. Comparison of stenting versus bypass surgery according to the completeness of revascularization in severe coronary artery disease: patient-level pooled analysis of the SYNTAX, PRECOMBAT, and BEST Trials. JACC Cardiovasc Interv 2017;10:1415-24.","journal-title":"JACC Cardiovasc Interv"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial","volume":"381","author":"Mohr","year":"2013","unstructured":"7. Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013;381:629-38.","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.athoracsur.2003.12.030","article-title":"Intraoperative ischemia and long-term events after minimally invasive coronary surgery","volume":"78","author":"Zimarino","year":"2004","unstructured":"8. Zimarino M, Gallina S, Di Fulvio M, et al. Intraoperative ischemia and long-term events after minimally invasive coronary surgery. Ann Thorac Surg 2004;78:135-41.","journal-title":"Ann Thorac Surg"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1001\/jama.2014.15095","article-title":"Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction","volume":"312","author":"Park","year":"2014","unstructured":"9. Park DW, Clare RM, Schulte PJ, et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. JAMA 2014;312:2019-27.","journal-title":"JAMA"},{"key":"ref9","unstructured":"10. Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-619."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jacc.2011.03.046","article-title":"Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis","volume":"58","author":"Vlaar","year":"2011","unstructured":"11. Vlaar PJ, Mahmoud KD, Holmes DR, et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol 2011;58:692-703.","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1056\/NEJMoa1305520","article-title":"Randomized trial of preventive angioplasty in myocardial infarction","volume":"369","author":"Wald","year":"2013","unstructured":"12. Wald DS, Morris JK, Wald NJ, et al. The PRAMI Investigators. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 2013;369:1115-23.","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.4244\/EIJV8I10A183","article-title":"Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design","volume":"8","author":"Kelly","year":"2013","unstructured":"13. Kelly DJ, McCann GP, Blackman D, et al. Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design. EuroIntervention 2013;8:1190-8.","journal-title":"EuroIntervention"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","article-title":"Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial","volume":"386","author":"Engstrom","year":"2015","unstructured":"14. Engstrom T, Kelbaek H, Helqvist S, et al. DANAMI-3-PRIMULTI Investigators. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial. Lancet 2015;386:665-71.","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jcin.2016.11.047","article-title":"Complete or culprit-only revascularization for patients with multivessel coronary artery disease undergoing percutaneous coronary intervention: a pairwise and network meta-analysis of randomized trials","volume":"10","author":"Elgendy","year":"2017","unstructured":"15. Elgendy IY, Mahmoud AN, Kumbhani DJ, et al. Complete or culprit-only revascularization for patients with multivessel coronary artery disease undergoing percutaneous coronary intervention: a pairwise and network meta-analysis of randomized trials. JACC Cardiovasc Interv 2017;10:315-24.","journal-title":"JACC Cardiovasc Interv"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jacc.2011.12.001","article-title":"ACCF\/SCAI\/STS\/AATS\/AHA\/ASNC\/HFSA\/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography","volume":"59","author":"MR","year":"2012","unstructured":"16. Patel MR, Dehmer GJ, Hirshfeld JW, et al. American College of Cardiology Foundation; American College of Cardiology Foundation Appropriate Use Criteria Task Force; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Thoracic Surgery; American Heart Association; American Society of Nuclear Cardiology; Society of Cardiovascular Computed Tomography. ACCF\/SCAI\/STS\/AATS\/AHA\/ASNC\/HFSA\/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2012;59:857-81.","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0735-1097(02)02049-1","article-title":"Exaggeration of nonculprit stenosis severity during acute myocardial infarction: implications for immediate multivessel revascularization","volume":"40","author":"Hanratty","year":"2002","unstructured":"17. Hanratty CG, Koyama Y, Rasmussen HH, et al. Exaggeration of nonculprit stenosis severity during acute myocardial infarction: implications for immediate multivessel revascularization. J Am Coll Cardiol 2002;40:911-6.","journal-title":"J Am Coll Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/CIRCINTERVENTIONS.110.955310","article-title":"Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction","volume":"3","author":"Sgura","year":"2010","unstructured":"18. Sgura FA, Bertelli L, Monopoli D, et al. Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction. Circ Cardiovasc Interv 2010;3:491-8.","journal-title":"Circ Cardiovasc Interv"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Patti G, De Caterina R, Abbate R, et al. Working Group on Thrombosis of the Italian Society of Cardiology. Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper. Eur Heart J 2014;35:2213-23b.","DOI":"10.1093\/eurheartj\/ehu279"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/eurheartj\/ehr471","article-title":"Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial","volume":"33","author":"Claessen","year":"2012","unstructured":"20. Claessen BE, Dangas GD, Weisz G, et al. Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial. Eur Heart J 2012;33:768-75.","journal-title":"Eur Heart J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.jacc.2016.07.744","article-title":"Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial","volume":"68","author":"Henriques","year":"2016","unstructured":"21. Henriques JP, Hoebers LP, Ramunddal T, et al. EXPLORE Trial Investigators. Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial. J Am Coll Cardiol 2016;68:1622-32.","journal-title":"J Am Coll Cardiol"},{"key":"ref21","unstructured":"22. Amsterdam EA, Wenger NK, Brindis RG, et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association for Clinical Chemistry. 2014 AHA\/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;64:e139-228."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","unstructured":"23. Roffi M, Patrono C, Collet JP, et al. Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267-315.","journal-title":"Eur Heart J"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Zimarino M, Cicchitti V, Genovesi E, et al. Isolated troponin increase after percutaneous coronary interventions: does it have prognostic relevance? Atherosclerosis 2012;221:297-302.","DOI":"10.1016\/j.atherosclerosis.2011.10.010"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0002-9149(01)02189-0","article-title":"Device selection in the treatment of in-stent restenosis with and without radiation (from the Gamma Radiation Trials)","volume":"89","author":"Ajani","year":"2002","unstructured":"25. Ajani AE, Waksman R, Zimarino M, et al. Device selection in the treatment of in-stent restenosis with and without radiation (from the Gamma Radiation Trials). Am J Cardiol 2002;89:137-44.","journal-title":"Am J Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1161\/CIRCULATIONAHA.106.612267","article-title":"Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era","volume":"113","author":"Hannan","year":"2006","unstructured":"26. Hannan EL, Racz M, Holmes DR, et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 2006;113:2406-12.","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jcin.2008.08.021","article-title":"Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes","volume":"2","author":"Hannan","year":"2009","unstructured":"27. Hannan EL, Wu C, Walford G, et al. Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes. JACC Cardiovasc Interv 2009;2:17-25.","journal-title":"JACC Cardiovasc Interv"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Shishehbor MH, Lauer MS, Singh IM, et al. In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? J Am Coll Cardiol 2007;49:849-54.","DOI":"10.1016\/j.jacc.2006.10.054"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1016\/j.jacc.2009.11.096","article-title":"Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation","volume":"55","author":"Tonino","year":"2010","unstructured":"29. Tonino PA, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 2010;55:2816-21.","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/j.jacc.2012.03.010","article-title":"Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score","volume":"59","author":"G\u00e9n\u00e9reux","year":"2012","unstructured":"30. G\u00e9n\u00e9reux P, Palmerini T, Caixeta A, et al. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. J Am Coll Cardiol 2012;59:2165-74.","journal-title":"J Am Coll Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jacc.2015.10.082","article-title":"Single-Staged Compared With Multi-Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial","volume":"67","author":"Sardella","year":"2016","unstructured":"31. Sardella G, Lucisano L, Garbo R, et al. Single-Staged Compared With Multi-Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial. J Am Coll Cardiol 2016;67:264-72.","journal-title":"J Am Coll Cardiol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jacc.2016.05.032","article-title":"Hybrid coronary revascularization for the treatment of multivessel coronary artery disease: a multicenter observational study","volume":"68","author":"Puskas","year":"2016","unstructured":"32. Puskas JD, Halkos ME, DeRose JJ, et al. Hybrid coronary revascularization for the treatment of multivessel coronary artery disease: a multicenter observational study. J Am Coll Cardiol 2016;68:356-65.","journal-title":"J Am Coll Cardiol"},{"key":"ref32","unstructured":"33. Fihn SD, Gardin JM, Abrams J, et al. American College of Cardiology Foundation; American heart Association Task Force on Practice Guidelines; American College of Physicians; American Association for Thoracic Surgery; Preventive Cardiovascular Nurses Association; Study for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. 2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012;60:e44-e164."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Force Members","year":"2013","unstructured":"34. Task Force Members, Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949-3003.","journal-title":"Eur Heart J"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys","year":"2009","unstructured":"35. Serruys PW, Morice MC, Kappetein AP, et al. the SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.113.001803","article-title":"Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score","volume":"128","author":"Farooq","year":"2013","unstructured":"36. Farooq V, Serruys PW, Bourantas CV, et al. Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score. Circulation 2013;128:141-51.","journal-title":"Circulation"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1161\/01.CIR.0000072790.23090.41","article-title":"Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography","volume":"107","author":"Hachamovitch","year":"2003","unstructured":"37. Hachamovitch R, Hayes SW, Friedman JD, et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-7.","journal-title":"Circulation"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1001\/jama.2011.916","article-title":"Appropriateness of percutaneous coronary intervention","volume":"306","author":"Chan","year":"2011","unstructured":"38. Chan PS, Patel MR, Klein LW, et al. Appropriateness of percutaneous coronary intervention. JAMA 2011;306:53-61.","journal-title":"JAMA"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1093\/eurheartj\/ehp315","article-title":"Appropriate myocardial revascularization: a joint viewpoint from an interventional cardiologist and a cardiac surgeon","volume":"30","author":"Wijns","year":"2009","unstructured":"39. Wijns W, Kolh P. Appropriate myocardial revascularization: a joint viewpoint from an interventional cardiologist and a cardiac surgeon. Eur Heart J 2009;30:2182-5.","journal-title":"Eur Heart J"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.300.15.1765","article-title":"Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention","volume":"300","author":"Lin","year":"2008","unstructured":"40. Lin GA, Dudley RA, Lucas FL, et al. Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA 2008;300:1765-73.","journal-title":"JAMA"},{"issue":"3","key":"ref40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa0807611","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention","volume":"360","author":"Tonino","year":"2009","unstructured":"41. Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360(3):213-24.","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.109.925396","article-title":"Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease","volume":"122","author":"Fearon","year":"2010","unstructured":"42. Fearon WF, Bornschein B, Tonino PA, et al. Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. Circulation 2010;122:2545-50.","journal-title":"Circulation"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jacc.2010.04.012","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study","volume":"56","author":"Pijls","year":"2010","unstructured":"43. Pijls NH, Fearon WF, Tonino PA, et al. Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010;56:177-84.","journal-title":"J Am Coll Cardiol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/2012.jama.11274","article-title":"Diagnostic accuracy of fractional flow reserve from anatomic CT angiography","volume":"308","author":"Min","year":"2012","unstructured":"44. Min JK, Leipsic J, Pencina MJ, et al. Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA 2012;308:1237-45.","journal-title":"JAMA"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1161\/CIRCULATIONAHA.109.872358","article-title":"Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease","volume":"120","author":"Watkins","year":"2009","unstructured":"45. Watkins S, McGeoch R, Lyne J, et al. Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease. Circulation 2009;120:2207-13.","journal-title":"Circulation"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jcin.2010.01.011","article-title":"Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: pre- and post-procedural evaluation by cardiac magnetic resonance imaging","volume":"3","author":"Kirschbaum","year":"2010","unstructured":"46. Kirschbaum SW, Springeling T, Boersma E, et al. Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: pre- and post-procedural evaluation by cardiac magnetic resonance imaging. JACC Cardiovasc Interv 2010;3:392-400.","journal-title":"JACC Cardiovasc Interv"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","unstructured":"47. De Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012;367:991-1001.","journal-title":"N Engl J Med"},{"issue":"4","key":"ref47","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ccd.25264","article-title":"Prevalence and management of coronary chronic total occlusions in a tertiary Veterans Affairs hospital","volume":"84","author":"Jeroudi","year":"2014","unstructured":"48. Jeroudi OM, Alomar ME, Michael TT, et al. Prevalence and management of coronary chronic total occlusions in a tertiary Veterans Affairs hospital. Catheter Cardiovasc Interv 2014;84(4):637-43.","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"49. Ng AK, Shah PB, Williams DO. Percutaneous revascularization of chronic total coronary occlusion: for whom? Circ Cardiovasc Interv 2017;10:e005512.","DOI":"10.1161\/CIRCINTERVENTIONS.117.005512"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"50. Tamburino C, Capranzano P, Capodanno D, et al. Percutaneous recanalization of chronic total occlusions: wherein lies the body of proof? Am Heart J 2013;165:133-42.","DOI":"10.1016\/j.ahj.2012.10.017"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jcin.2009.10.029","article-title":"In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan)","volume":"3","author":"Morino","year":"2010","unstructured":"51. Morino Y, Kimura T, Hayashi Y, et al. J-CTO Registry Investigators. In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan). JACC Cardiovasc Interv 2010;3:143-51.","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"ref51","doi-asserted-by":"publisher","first-page":"472","DOI":"10.4244\/EIJV7I4A77","article-title":"In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry","volume":"7","author":"Galassi","year":"2011","unstructured":"52. Galassi AR, Tomasello SD, Reifart N, et al. In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry. EuroIntervention 2011;7(4):472-9.","journal-title":"EuroIntervention"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1056\/NEJM199601253340402","article-title":"Coronary bypass surgery with internal-thoracic-artery grafts-effects on survival over a 15-year period","volume":"334","author":"Cameron","year":"1996","unstructured":"53. Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with internal-thoracic-artery grafts-effects on survival over a 15-year period. N Engl J Med 1996;334:216-9.","journal-title":"N Engl J Med"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1056\/NEJMoa1610021","article-title":"Randomized trial of bilateral versus single internal-thoracic-artery grafts","volume":"375","author":"Taggart","year":"2016","unstructured":"54. Taggart DP, Altman DG, Gray AM, et al. ART Investigators. Randomized trial of bilateral versus single internal-thoracic-artery grafts. N Engl J Med 2016;375:2540-9.","journal-title":"N Engl J Med"}],"container-title":["Interventional Cardiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.icrjournal.com\/articles\/complete-revascularisation-mandated-all-patients-multivessel-coronary-artery-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T09:36:12Z","timestamp":1599644172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.icrjournal.com\/articles\/complete-revascularisation-mandated-all-patients-multivessel-coronary-artery-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":54,"journal-issue":{"issue":"01","published-print":{"date-parts":[[2017]]}},"alternative-id":["icr.2017:23:1"],"URL":"https:\/\/doi.org\/10.15420\/icr.2017:23:1","relation":{},"ISSN":["1756-1477"],"issn-type":[{"type":"print","value":"1756-1477"}],"subject":[],"published":{"date-parts":[[2017]]}}}